DNASE1L3 and systemic lupus erythematosus: The data do however suggest that it is not the DNase-I activity per se that is affected in these SLE patients but rather DNase-I is prevented from degrading chromatin, potentially by sterically blocking access for DNase-I by dsDNA antibodies generated during the disease.